Drug Shortage Report for AMPICILLIN SODIUM FOR INJECTION, USP
| Report ID | 128031 |
| Drug Identification Number | 00872652 |
| Brand name | AMPICILLIN SODIUM FOR INJECTION, USP |
| Common or Proper name | AMPICILLIN SODIUM INJ 500MG |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | AMPICILLIN |
| Strength(s) | 500MG |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS |
| Packaging size | 10PK |
| ATC code | J01CA |
| ATC description | BETA-LACTAM ANTIBACTERIALS, PENICILLINS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2020-11-04 |
| Estimated end date | 2021-02-28 |
| Actual end date | 2021-03-17 |
| Shortage status | Resolved |
| Updated date | 2021-03-18 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2020-11-06 | English | Compare |
| v2 | 2020-11-06 | French | Compare |
| v3 | 2021-01-28 | English | Compare |
| v4 | 2021-01-28 | French | Compare |
| v5 | 2021-03-04 | English | Compare |
| v6 | 2021-03-04 | French | Compare |
| v7 | 2021-03-18 | English | Compare |
| v8 | 2021-03-18 | French | Compare |
Showing 1 to 8 of 8